Tobacco smoke carcinogens and lung cancer
SS Hecht - Journal of the national cancer institute, 1999 - academic.oup.com
The complexity of tobacco smoke leads to some confusion about the mechanisms by which
it causes lung cancer. Among the multiple components of tobacco smoke, 20 carcinogens …
it causes lung cancer. Among the multiple components of tobacco smoke, 20 carcinogens …
Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention
SS Hecht - The lancet oncology, 2002 - thelancet.com
Much is now known about the carcinogens in cigarette smoke, their conversion to forms that
react with DNA, and the miscoding properties of the resulting DNA adducts that cause the …
react with DNA, and the miscoding properties of the resulting DNA adducts that cause the …
Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers
H Shigematsu, L Lin, T Takahashi… - Journal of the …, 2005 - academic.oup.com
Background: Mutations in the tyrosine kinase (TK) domain of the epidermal growth factor
receptor (EGFR) gene in lung cancers are associated with increased sensitivity of these …
receptor (EGFR) gene in lung cancers are associated with increased sensitivity of these …
Inactivation of LKB1/STK11 Is a Common Event in Adenocarcinomas of the Lung
Frequent losses of chromosome 19p have recently been observed in sporadic lung
adenocarcinomas, targeting the location of a critical tumor suppressor gene. Here we …
adenocarcinomas, targeting the location of a critical tumor suppressor gene. Here we …
Tumor progression and metastasis
J Yokota - Carcinogenesis, 2000 - academic.oup.com
It is now widely accepted that cancer is attributed to the accumulation of genetic alterations
in cells. Thus, to understand the molecular mechanisms of cancer metastasis, it is …
in cells. Thus, to understand the molecular mechanisms of cancer metastasis, it is …
Molecular biology of lung cancer: clinical implications
JE Larsen, JD Minna - Clinics in chest medicine, 2011 - chestmed.theclinics.com
Lung cancer is the leading cause of cancer-related death in men and women in the United
States, accounting for approximately 28% of total cancer deaths in 2010 despite comprising …
States, accounting for approximately 28% of total cancer deaths in 2010 despite comprising …
Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression
DG Burbee, E Forgacs… - Journal of the …, 2001 - academic.oup.com
Background: The recently identified RASSF1 locus is located within a 120-kilobase region of
chromosome 3p21. 3 that frequently undergoes allele loss in lung and breast cancers. We …
chromosome 3p21. 3 that frequently undergoes allele loss in lung and breast cancers. We …
Issues and progress with protein kinase inhibitors for cancer treatment
J Dancey, EA Sausville - Nature reviews Drug discovery, 2003 - nature.com
Identification of the key roles of protein kinases in cancer has led to extensive efforts to
develop kinase inhibitors for the treatment of a wide range of cancers, and more than 30 …
develop kinase inhibitors for the treatment of a wide range of cancers, and more than 30 …
The 630-kb lung cancer homozygous deletion region on human chromosome 3p21. 3: identification and evaluation of the resident candidate tumor suppressor genes
MI Lerman, JD Minna… - Cancer research, 2000 - AACR
We used overlapping and nested homozygous deletions, contig building, genomic
sequencing, and physical and transcript mapping to further define a∼ 630-kb lung cancer …
sequencing, and physical and transcript mapping to further define a∼ 630-kb lung cancer …
Aberrant promoter methylation of multiple genes in non-small cell lung cancers
S Zöchbauer-Müller, KM Fong, AK Virmani… - Cancer research, 2001 - AACR
Aberrant methylation of CpG islands acquired in tumor cells in promoter regions is one
method for loss of gene function. We determined the frequency of aberrant promoter …
method for loss of gene function. We determined the frequency of aberrant promoter …